Insufficient scRNA-seq data for expression of MOCS3 at single-cell level.
Insufficient scRNA-seq data for expression of MOCS3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 363.57 | 459 / 459 | 100% | 12.33 | 1116 / 1118 |
skin | 100% | 637.33 | 1809 / 1809 | 100% | 11.89 | 471 / 472 |
uterus | 100% | 397.78 | 170 / 170 | 100% | 9.90 | 457 / 459 |
esophagus | 100% | 448.49 | 1438 / 1445 | 100% | 9.57 | 183 / 183 |
stomach | 99% | 371.33 | 357 / 359 | 100% | 13.23 | 286 / 286 |
bladder | 100% | 434.05 | 21 / 21 | 99% | 10.76 | 500 / 504 |
intestine | 100% | 429.43 | 963 / 966 | 99% | 13.33 | 524 / 527 |
thymus | 100% | 356.62 | 650 / 653 | 100% | 8.55 | 602 / 605 |
prostate | 100% | 366.91 | 245 / 245 | 99% | 8.20 | 497 / 502 |
brain | 98% | 310.76 | 2602 / 2642 | 100% | 8.91 | 705 / 705 |
kidney | 100% | 254.54 | 89 / 89 | 98% | 6.85 | 886 / 901 |
ovary | 98% | 363.85 | 177 / 180 | 100% | 14.13 | 430 / 430 |
liver | 100% | 328.25 | 226 / 226 | 97% | 5.61 | 394 / 406 |
pancreas | 98% | 257.94 | 320 / 328 | 99% | 6.97 | 176 / 178 |
adrenal gland | 100% | 481.29 | 258 / 258 | 96% | 6.65 | 221 / 230 |
lung | 87% | 256.89 | 505 / 578 | 100% | 9.41 | 1154 / 1155 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.32 | 29 / 29 |
spleen | 100% | 561.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.13 | 1 / 1 |
adipose | 100% | 311.06 | 1202 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 365.80 | 800 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 8.68 | 79 / 80 |
blood vessel | 98% | 282.63 | 1314 / 1335 | 0% | 0 | 0 / 0 |
heart | 89% | 204.66 | 766 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 69% | 270.73 | 637 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002098 | Biological process | tRNA wobble uridine modification |
GO_0034227 | Biological process | tRNA thio-modification |
GO_0006777 | Biological process | Mo-molybdopterin cofactor biosynthetic process |
GO_0032447 | Biological process | protein urmylation |
GO_0002143 | Biological process | tRNA wobble position uridine thiolation |
GO_0043545 | Biological process | molybdopterin cofactor metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0016779 | Molecular function | nucleotidyltransferase activity |
GO_0061605 | Molecular function | molybdopterin-synthase adenylyltransferase activity |
GO_0004792 | Molecular function | thiosulfate sulfurtransferase activity |
GO_0016783 | Molecular function | sulfurtransferase activity |
GO_0061604 | Molecular function | molybdopterin-synthase sulfurtransferase activity |
GO_0042292 | Molecular function | URM1 activating enzyme activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | MOCS3 |
Protein name | Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) (Molybdopterin synthase sulfurylase) (MPT synthase sulfurylase) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)] |
Synonyms | UBA4 |
Description | FUNCTION: Plays a central role in 2-thiolation of mcm(5)S(2)U at tRNA wobble positions of cytosolic tRNA(Lys), tRNA(Glu) and tRNA(Gln). Also essential during biosynthesis of the molybdenum cofactor. Acts by mediating the C-terminal thiocarboxylation of sulfur carriers URM1 and MOCS2A. Its N-terminus first activates URM1 and MOCS2A as acyl-adenylates (-COAMP), then the persulfide sulfur on the catalytic cysteine is transferred to URM1 and MOCS2A to form thiocarboxylation (-COSH) of their C-terminus. The reaction probably involves hydrogen sulfide that is generated from the persulfide intermediate and that acts as a nucleophile towards URM1 and MOCS2A. Subsequently, a transient disulfide bond is formed. Does not use thiosulfate as sulfur donor; NFS1 acting as a sulfur donor for thiocarboxylation reactions. . |
Accessions | ENST00000244051.3 O95396 |